Clinical Trial Update: Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids [Phase 3]

View source ↗

Summary

Phase 3 clinical trial on masitinib for severe persistent asthma treated with oral corticosteroids has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Masitinib (masitinib)

Snippet

Sponsor: AB Science | Conditions: Asthma | Phase 3 | Status: COMPLETED